West Pharmaceutical Services | WST - Operating Expenses

Stock Price
306.16
Daily Change
-3.54 -1.14%
Monthly
23.94%
Yearly
42.70%
Q2 Forecast
267.71

West Pharmaceutical Services reported $2.99B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Align Technology USD 822.85M 11.8M Dec/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Dentsply International USD 423M 1.06B Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 1.89B 3.09B Dec/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Utah Medical Products USD 6.6M 354K Dec/2025
West Pharmaceutical Services USD 2.99B 2.35B Mar/2026